PLEASANTON, Calif., May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with ...

Bruker and 10x Genomics have agreed to settle a patent dispute relating to products originally developed by Nanostring, a company Bruker acquired in 2024. Under the settlement, whose financial ...

10x Genomics TXG has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s ...